Q2 2020 13F Holders as of 6/30/2020
-
Type / Class
-
Equity / Common Stock
-
Shares outstanding
-
27.1M
-
Number of holders
-
107
-
Total 13F shares, excl. options
-
12.1M
-
Shares change
-
+7.42M
-
Total reported value, excl. options
-
$568M
-
Value change
-
+$352M
-
Put/Call ratio
-
1.35
-
Number of buys
-
84
-
Number of sells
-
-24
-
Price
-
$46.74
Significant Holders of Arcturus Therapeutics Holdings Inc. - Common Stock (ARCT) as of Q2 2020
124 filings reported holding ARCT - Arcturus Therapeutics Holdings Inc. - Common Stock as of Q2 2020.
Arcturus Therapeutics Holdings Inc. - Common Stock (ARCT) has 107 institutional shareholders that have filed 13F forms with the Securities Exchange Commission (SEC).
These institutions hold a total of 12.1M shares
of 27.1M outstanding shares and own 44.76% of the company stock.
Largest 10 shareholders include ARK Investment Management LLC (1.92M shares), BlackRock Inc. (963K shares), VANGUARD GROUP INC (871K shares), Cormorant Asset Management, LP (800K shares), CITADEL ADVISORS LLC (698K shares), FMR LLC (675K shares), FEDERATED HERMES, INC. (615K shares), PRICE T ROWE ASSOCIATES INC /MD/ (518K shares), EARNEST PARTNERS LLC (271K shares), and STATE STREET CORP (258K shares).
This table shows the top 107 institutional shareholders of the company equity. This data is sourced directly from the SEC via 13F filings.
| Investor |
Option |
Weight % |
Change % |
Value $ |
* Price $ |
Shares |
Share Change |
Activity |
Report Period |
* Reported Price is the price of the security as of the portfolio date. This value is significant in that it is the last known price at which the security was still held.
An asterisk sign (*) next to the price indicates that the price is likely invalid.